Brooklyn Investment Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.97M Buy
6,731
+2,481
+58% +$815K 0.06% 282
2025
Q4
$1.48M Buy
4,250
+2,050
+93% +$693K 0.07% 235
2025
Q3
$839K Sell
2,200
-61
-3% -$19K 0.11% 180
2025
Q2
$879K Buy
2,261
+48
+2% +$19.3K 0.12% 180
2025
Q1
$963K Buy
2,213
+758
+52% +$304K 0.21% 98
2024
Q4
$537K Sell
1,455
-131
-8% -$54.8K 0.16% 109
2024
Q3
$825K Buy
1,586
+71
+5% +$37.9K 0.27% 77
2024
Q2
$782K Hold
1,515
0.34% 70
2024
Q1
$782K Buy
1,515
+228
+18% +$113K 0.34% 70
2023
Q4
$607K Buy
+1,287
New +$595K 0.29% 80

Other funds holding ELV

Brooklyn Investment Group's ELV Position: Q1 2026 in Review

Brooklyn Investment Group increased its Elevance Health (ELV) stake by 58% in Q1 2026, buying an estimated $815K and bringing the position to 6,731 shares worth $1.97M. The position accounts for 0.06% of the portfolio, ranked #282.

Brooklyn Investment Group first reported a position in ELV in Q4 2023 and has held it in 10 quarters since. 1,470 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Brooklyn Investment Group held 6,731 shares of Elevance Health worth $1.97M as of Q1 2026.
  • Brooklyn Investment Group bought 2,481 Elevance Health shares in Q1 2026, an estimated $815K.
  • Elevance Health made up 0.06% of Brooklyn Investment Group's portfolio in Q1 2026, its #282 holding.
  • Brooklyn Investment Group first reported a position in Elevance Health in Q4 2023 and has held it in 10 quarters since.
  • 1,470 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.